GE HealthCare acquires $945m Sofie Biosciences
Global MedTech and diagnostocs leader GE HealthCare has acquired Sofie Biosciences, a privately-held developer of radiopharmaceuticals and molecular imaging diagnostics, in a transaction valued at $945 million. The deal marks a major step forward in GE HealthCare’s strategy to expand its precision diagnostics business and secure greater operational control over the highly complex and time-sensitive radiopharmaceutical supply chain. Molecular imaging…